Building on EY's recent report, "The power of three," Global Life Sciences Leader Glen Giovannetti shares his thoughts on what entrepreneurship means to life sciences.
Fostering entrepreneurship in the life sciences
The life sciences industry and digital risk
Pulse of the industry - medical technology report 2013
Cash on prescription 2013
Beyond Borders: global biotech report 2013
Life Sciences deal sentiment scorecard
mHealth: Mobile tech poised to enable new era in health care
The shifting pharmaceutical industry landscape
Pharma's $100 billion growth gap
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas:
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
Have investor-friendly capital allocation and new competitors upended the world order in M&A? Find out how the biopharma sector is facing this challenge.